As the industry struggles with new competitive pressure, the move is on from batch to continuous processing in an effort to increase manufacturing agility, improve product quality, and lower operational costs. The pharmaceutical space is an industry in transition. To… Continue Reading
How the American opiate epidemic was started by one pharmaceutical company. The state of Kentucky may finally get its deliverance. After more than seven years of battling the evasive legal tactics of Purdue Pharma, 2015 may be the year that… Continue Reading
As the saying goes, all good things must come to an end. And for pharma, that means banking on the one-size-fits-all model of drug development. Companion diagnostics, a relatively new concept that’s hitting the frontlines of drug discovery and development,… Continue Reading
Pharmaceutical companies have more power than ever, and the American people are paying the price—too often with our lives. By now you have probably seen John Oliver’s comic take on the pharmaceutical industry’s influence on doctors’ prescribing habits. Media outlets… Continue Reading
February 18, 2015 NEW YORK (GenomeWeb) – The US Food and Drug Administration is planning to put the $10 million the agency expects to receive under the President’s Precision Medicine Initiative to set up databases that can help inform its… Continue Reading
Researchers may develop saliva test to diagnose autism Date: February 16, 2015 Source: Clarkson University Summary: A spit test may one day be able to diagnose autism according to new research. Scientists have published the first study showing that children… Continue Reading
Fed-up MD Anderson oncologist jumps on social media to fight drug prices. Flush with success in negotiating discounts for hepatitis C drugs, payers are promising to strong-arm drugmakers in other treatment classes, too–cholesterol and cancer, for instance. They’ll have more… Continue Reading
While startups like Uber and Snapchat have garnered giant valuations recently, another sector looks like it might be getting just as overheated. Big pharma firms and investors have been showering billions on speculative companies that have never produced a viable drug. For four years… Continue Reading
The 2015 Harris corporate reputation poll is out and the news for Big Pharma isn’t good, to say the least. In the poll—which measures the “reputation quotient” of the most visible American companies among the general public—Big Pharma ranked ninth… Continue Reading
Plugging personalized, or precision, medicine, President Obama recently announced funding for a new “research consortium” that would collect a variety of information from large numbers of people for a database. He failed to acknowledge, however, that the risk-averse posture and… Continue Reading
Allergan AGN +0.68%’s Botox was the first product to change the face of women and even men in the last decade. Today we are seeing a whole suite of companies coming up with pharmaceutical magic potions to keep people feeling… Continue Reading
One of the FDA’s advisory committees has circled March 17 on the calendar for its review of Celltrion‘s Remsima, a biosimilar of Johnson & Johnson’s ($JNJ) Remicade that is now in line to become the second knockoff to reach the… Continue Reading
Drug companies are a bit like high-school boyfriends,” Oliver said. “They’re much more concerned with getting inside you than being effective once they’re in there. Oliver pointed out pharmaceutical companies spent more than $24 billion marketing to doctors in 2012.… Continue Reading
The excitement surrounding personalized, genetics-based medicine has so far outpaced the science. Credit Photograph by Dilip Vishwanat/The New York Times/Redux Last Friday, in a speech at the White House, President Obama unveiled what he called his Precision Medicine Initiative, a… Continue Reading
February 9, 2015 NEW YORK (GenomeWeb) – Continuing a buying spree, Roche today announced it acquired German translational oncology and genomics firm Signature Diagnostics for an undisclosed amount. Based in Potsdam, Signature develops large blood plasma and tissue biobanks in… Continue Reading
Myriad Settles BRCA Patent Case with Quest; Only GeneDx Lawsuit Remains Feb. 9, 2015 NEW YORK (GenomeWeb) – Quest Diagnostics and Myriad Genetics have settled their patent dispute related to BRCA testing. Myriad along with its co-patent holders and Quest… Continue Reading
(Reuters) – Achillion Pharmaceuticals Inc said its experimental hepatitis C drug, when used in combination with Gilead Sciences Inc’s Sovaldi, eradicated signs of the virus after six weeks of therapy, sending its shares up before the opening bell. If the… Continue Reading
February 4, 2015 Last week in Berlin more than 15 countries, along with the European Commission, the Gates Foundation and others, pledged over US$7.5 billion to buy vaccines for the children of the world’s poorest countries for the next five… Continue Reading
Pfizer CEO Ian Read is dipping into the pharma giant’s big reserve of cash to gobble up Hospira ($HSP), one of the pioneers in the move to develop biosimilars of blockbuster biologics. The Big Pharma is paying $90 a share… Continue Reading
Life is important, and also are the components that go into supporting it. Diagnostics – the chemistry / analysis that we rely on – day to day – plays a far greater role than you would think. The Diagnostic Field… Continue Reading